Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Defining ventilator-associated pneumonia: a (de)construction concept.

Dalmora CH, Deutschendorf C, Nagel F, dos Santos RP, Lisboa T.

Rev Bras Ter Intensiva. 2013 Apr-Jun;25(2):81-6. doi: 10.5935/0103-507X.20130017. English, Portuguese. No abstract available.

2.

Preventing ventilator-associated pneumonia: does the evidence support the practice?

O'Grady NP, Murray PR, Ames N.

JAMA. 2012 Jun 20;307(23):2534-9. doi: 10.1001/jama.2012.6445.

3.

Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections.

Macherla C, Sanchez DA, Ahmadi MS, Vellozzi EM, Friedman AJ, Nosanchuk JD, Martinez LR.

Front Microbiol. 2012 Jun 8;3:193. doi: 10.3389/fmicb.2012.00193. eCollection 2012.

5.

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.

Horn MP, Zuercher AW, Imboden MA, Rudolf MP, Lazar H, Wu H, Hoiby N, Fas SC, Lang AB.

Antimicrob Agents Chemother. 2010 Jun;54(6):2338-44. doi: 10.1128/AAC.01142-09. Epub 2010 Mar 22.

6.

Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B, Weiss K, Zhanel GG.

Can J Infect Dis Med Microbiol. 2008 Jan;19(1):19-53.

7.

Staffing level: a determinant of late-onset ventilator-associated pneumonia.

Hugonnet S, Uçkay I, Pittet D.

Crit Care. 2007;11(4):R80.

Supplemental Content

Support Center